Dr. Barry Dworkin

If the reported two-dose Pfizer pediatric COVID vaccine data to date for two to four-year-olds did not produce a strong enough immune response, do they have more data to support their application for FDA approval?

Medical Mythbusting Commentary for February 1, 2022

Source:
Pfizer is expected to ask the F.D.A. to authorize its Covid vaccine for children under 5.

Related posts:

  1. Calgary obstetric clinic posts notice not to bring unvaccinated children to their office to reduce the risk of harm to pregnant women and their newborn children. To those complaining, what are your health policy reasons for rejecting this proposal?
  2. Quebec proposes one Covid vaccine for those who were previously infected without any substantive evidence to support such a policy change.
  3. More evidence emerging that COVID vaccines are a three-dose series like many other vaccines that we receive. U.S. preprint study suggests that fully vaccinated Veterans are experiencing breakthrough infections six months after second dose #VaccinesWork
  4. Moderna CEO should quell their speculative and alarmist comments about Omicron. In times of uncertainty, statements should be calm, measured, humble, and neutral in tone. Answers likely forthcoming in 1-2 wks. Solutions will follow thereafter.